129 related articles for article (PubMed ID: 15698431)
1. Time-evolution and reversibility of strontium-induced osteomalacia in chronic renal failure rats.
Oste L; Bervoets AR; Behets GJ; Dams G; Marijnissen RL; Geryl H; Lamberts LV; Verberckmoes SC; Van Hoof VO; De Broe ME; D'Haese PC
Kidney Int; 2005 Mar; 67(3):920-30. PubMed ID: 15698431
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent effects of strontium on bone of chronic renal failure rats.
Schrooten I; Behets GJ; Cabrera WE; Vercauteren SR; Lamberts LV; Verberckmoes SC; Bervoets AJ; Dams G; Goodman WG; De Broe ME; D'Haese PC
Kidney Int; 2003 Mar; 63(3):927-35. PubMed ID: 12631073
[TBL] [Abstract][Full Text] [Related]
3. Strontium causes osteomalacia in chronic renal failure rats.
Schrooten I; Cabrera W; Goodman WG; Dauwe S; Lamberts LV; Marynissen R; Dorriné W; De Broe ME; D'Haese PC
Kidney Int; 1998 Aug; 54(2):448-56. PubMed ID: 9690211
[TBL] [Abstract][Full Text] [Related]
4. Moderate strontium loading induces rickets in rats with mild chronic renal failure.
Fischer DC; Jensen C; Rahn A; Salewski B; Kundt G; D'Haese PC; Haffner D; Behets GJ
Kidney Blood Press Res; 2011; 34(6):375-81. PubMed ID: 21654178
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent effects of strontium on osteoblast function and mineralization.
Verberckmoes SC; De Broe ME; D'Haese PC
Kidney Int; 2003 Aug; 64(2):534-43. PubMed ID: 12846748
[TBL] [Abstract][Full Text] [Related]
6. [Effect of strontium on bone metabolism in hemodialysis patients].
Gerstenfeld S; Hinojosa L; Serrano Arias M; Menéndez Rodríguez P; Fernández Martín JL; Marchante JM; García Alonso JI; Sanz-Medel A; Cannata Andía JB
Nefrologia; 2003; 23 Suppl 2():52-6. PubMed ID: 12778855
[TBL] [Abstract][Full Text] [Related]
7. Aluminum administration in the rat separately affects the osteoblast and bone mineralization.
Rodriguez M; Felsenfeld AJ; Llach F
J Bone Miner Res; 1990 Jan; 5(1):59-67. PubMed ID: 2309580
[TBL] [Abstract][Full Text] [Related]
8. Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure?
Behets GJ; Dams G; Vercauteren SR; Damment SJ; Bouillon R; De Broe ME; D'Haese PC
J Am Soc Nephrol; 2004 Aug; 15(8):2219-28. PubMed ID: 15284308
[TBL] [Abstract][Full Text] [Related]
9. Low bone turnover in patients with renal failure.
Couttenye MM; D'Haese PC; Verschoren WJ; Behets GJ; Schrooten I; De Broe ME
Kidney Int Suppl; 1999 Dec; 73():S70-6. PubMed ID: 10633468
[TBL] [Abstract][Full Text] [Related]
10. The evolution of osteomalacia in the rat with acute aluminum toxicity.
Rodriguez M; Felsenfeld AJ; Llach F
J Bone Miner Res; 1989 Oct; 4(5):687-96. PubMed ID: 2816514
[TBL] [Abstract][Full Text] [Related]
11. Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).
Visser WJ; Van de Vyver FL
Clin Nephrol; 1985; 24 Suppl 1():S30-6. PubMed ID: 3915958
[TBL] [Abstract][Full Text] [Related]
12. Development and reversibility of impaired mineralization associated with lanthanum carbonate treatment in chronic renal failure rats.
Bervoets AR; Oste L; Behets GJ; Dams G; Blust R; Marynissen R; Geryl H; De Broe ME; D'Haese PC
Bone; 2006 Jun; 38(6):803-10. PubMed ID: 16412714
[TBL] [Abstract][Full Text] [Related]
13. Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication.
Charhon SA; Chavassieux PM; Chapuy MC; Boivin GY; Meunier PJ
J Lab Clin Med; 1985 Aug; 106(2):123-31. PubMed ID: 2410522
[TBL] [Abstract][Full Text] [Related]
14. Iron lactate-induced osteomalacia in association with osteoblast dynamics.
Matsushima S; Torii M; Ozaki K; Narama I
Toxicol Pathol; 2003; 31(6):646-54. PubMed ID: 14585733
[TBL] [Abstract][Full Text] [Related]
15. Role of dietary phosphorus and degree of uremia in the development of renal bone disease in rats.
Oste L; Behets GJ; Dams G; Bervoets AR; Marynissen RL; Geryl H; Van Hoof VO; De Broe ME; D'Haese PC
Ren Fail; 2007; 29(1):1-12. PubMed ID: 17365904
[TBL] [Abstract][Full Text] [Related]
16. Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure.
Dunstan CR; Evans RA; Hills E; Wong SY; Alfrey AC
Calcif Tissue Int; 1984 Mar; 36(2):133-8. PubMed ID: 6430496
[TBL] [Abstract][Full Text] [Related]
17. Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect.
Grynpas MD; Hamilton E; Cheung R; Tsouderos Y; Deloffre P; Hott M; Marie PJ
Bone; 1996 Mar; 18(3):253-9. PubMed ID: 8703581
[TBL] [Abstract][Full Text] [Related]
18. Animal model of aluminum-induced osteomalacia: role of chronic renal failure.
Robertson JA; Felsenfeld AJ; Haygood CC; Wilson P; Clarke C; Llach F
Kidney Int; 1983 Feb; 23(2):327-35. PubMed ID: 6842959
[TBL] [Abstract][Full Text] [Related]
19. Extent of alkaline phosphatase cytochemistry vs. extent of tetracycline fluorescence in the evaluation of histodynamic variables of bone formation.
Ballanti P; Coen G; Taggi F; Mazzaferro S; Perruzza I; Bonucci E
Bone; 1995 May; 16(5):493-8. PubMed ID: 7654463
[TBL] [Abstract][Full Text] [Related]
20. Restoration of bone mineralization by cinacalcet is associated with a significant reduction in calcitriol-induced vascular calcification in uremic rats.
De Schutter TM; Behets GJ; Jung S; Neven E; D'Haese PC; Querfeld U
Calcif Tissue Int; 2012 Nov; 91(5):307-15. PubMed ID: 22926202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
